A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

IRB/UVA Tracking #
20629
Contact
Erica Stallard
Contact Email
Contact Phone
Phase
I/II
Primary purpose
Treatment
Cancer PI
Craig Portell
Status
OPEN TO ACCRUAL